go back

Hawaii rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Professionalmedian $489,779 · 10th–90th $467,735–$562,3410%50%10th90th$489,779$1.0K$5.0K$20.0K$100.0K$500.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $562,341.33
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $588,843.66
HMSA
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$467,735.14 / $467,735.14 / $467,735.14
Kaiser Permanente
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$457,088.19 / $588,843.66 / $741,310.24
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$363,078.05 / $489,778.82 / $549,540.87